FDA Adverse Event Injury Summary report: N

TOTAL ASR ACET IMP SIZE 56

MDR report key: 2822461 · Received November 7, 2012

Report

Report Number
1818910-2012-24366
Event Type
Injury
Date Received
November 7, 2012
Date of Event
May 30, 2012
Report Date
October 13, 2014
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KWA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA.

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Description of Event or Problem · 1

NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGACY SYSTEM) COMPLAINT NUMBER (B)(4) REASON FOR ORIGINAL COMPLAINT - ASR REVISION, RIGHT, RESURFACING, REASON FOR REVISION: PAIN/ METALLOSIS. UPDATE - ATTACHED SCF, AMENDED IMPLANT DATE, ADDED ADDITIONAL HOSPITAL AND ADDITIONAL REASON FOR REVISION. TAKEN FROM SCF DATED 13TH OCTOBER 2014 AND CLAIMSUITE DATED 16TH OCTOBER 2014. REASON(S) FOR REVISION: ALVAL / SOFT TISSUE REACTION.

Description of Event or Problem · 1

ASR REVISION; RIGHT RESURFACING; REASON FOR REVISION: PAIN; METALLOSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TOTAL ASR ACET IMP SIZE 56 HIP ACETABULAR CUP KWA DEPUY INTERNATIONAL LTD. 8010379 1826587

Patients

Seq Age Sex Outcome Treatment
1 66 YR Required Intervention